Table 4. Adjuvant therapy risk assessment.
Risk level | Radiotherapy | Chemotherapy |
---|---|---|
Low risk, n (%) | 7 (17) | 27 (64) |
Intermediate risk, n (%) | 11 (26) | NA |
High risk, n (%) | 24 (57) | 15 (36) |
NA.
For all tumours that are stage I, n = 42.
Radiotherapy risk assessment was assessed on the basis of zero risk factors (low), one risk factor (intermediate), or at least two (high) of the following risk factors: grade 3 endometrioid or non-endometrioid histotype; at least outer-half myometrial invasion; lymphovascular invasion.
Chemotherapy risk assessment was assessed on the basis of one (low) or two (high) of the following risk factors: grade 3 endometrioid or non-endometrioid histotype; at least deep myometrial invasion.